The aims of this study were to determine risk factors for morbidity associated with laparoscopic ileocolic resection (LICR) for Crohn’s disease (CD) and whether the addition of a diverting ileostomy is associated with reduced morbidity.
Patients undergoing LICR for primary CD at our institution from 2005 to 2015 included in a prospectively maintained database were assessed. The decision to perform a diverting ileostomy was left at the discretion of the operating surgeon. Demographics, disease-related, and treatment-related variables were evaluated using univariate and multivariate analyses as possible factors associated with diverting ileostomy creation and 30-day perioperative septic complications (anastomotic leaks and/or abscess). Use of any immunosuppressive medication was defined as use of steroids, biologics, and immunomodulators either alone or in combination.
For 409 patients, mortality was nil, overall morbidity rate was 40.6%, conversion rate 9.3%, and septic morbidity rate 7.6%. A diverting stoma was created in 22% of cases and was independently associated with BMI < 18.5 kg/m2 (P = 0.001), low serum albumin levels (P = 0.006), and longer operative time (P = 0.003). Use of any immunosuppressive medication was the only variable independently associated with septic complications, both in the overall population (OR 2.7, P = 0.036) and in the subgroup of undiverted patients (OR 3.1, P = 0.031). There was no association between septic morbidity and ileostomy creation, anastomotic configuration, penetrating disease, combined procedures (other resection or strictureplasty), BMI, albumin levels, and operative times.
LICR is safe in selected cases of complex penetrating disease, including when combined procedures are necessary. Our data are unable to prove that a diverting stoma is associated with reduced morbidity.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Myrelid P et al (2009) Thiopurine therapy is associated with postoperative intra-abdominal septic complications in abdominal surgery for Crohn's disease. Dis Colon Rectum 52(8):1387–1394
Dasari BV, McKay D, Gardiner K (2011) Laparoscopic versus Open surgery for small bowel Crohn's disease. Cochrane Database Syst Rev 1:Cd006956
Patel SV et al (2013) Laparoscopic surgery for Crohn's disease: a meta-analysis of perioperative complications and long term outcomes compared with open surgery. BMC Surg 13:14
Gajendran M et al (2018) Ileocecal anastomosis type significantly influences long-term functional status, quality of life, and healthcare utilization in postoperative crohn's disease patients independent of inflammation recurrence. Am J Gastroenterol 113(4):576–583
Maartense S et al (2006) Laparoscopic-assisted versus open ileocolic resection for Crohn's disease: a randomized trial. Ann Surg 243(2):143–149
Stocchi L, Milsom JW, Fazio VW (2008) Long-term outcomes of laparoscopic versus open ileocolic resection for Crohn's disease: follow-up of a prospective randomized trial. Surgery 144(4):622–627
Eshuis EJ et al (2010) Long-term outcomes following laparoscopically assisted versus open ileocolic resection for Crohn's disease. Br J Surg 97(4):563–568
Kristo I et al (2016) Minimal-invasive approach for penetrating Crohn's disease is not associated with increased complications. Surg Endosc 30(12):5239–5244
Pokala N et al (2005) Elective laparoscopic surgery for benign internal enteric fistulas: a review of 43 cases. Surg Endosc 19(2):222–225
Alves A et al (2007) Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn's disease: a multivariate analysis in 161 consecutive patients. Dis Colon Rectum 50(3):331–336
Aberra FN et al (2003) Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. Gastroenterology 125(2):320–327
El-Hussuna A et al (2013) The effect of anti-tumor necrosis factor alpha agents on postoperative anastomotic complications in Crohn's disease: a systematic review. Dis Colon Rectum 56(12):1423–1433
Yamamoto T, Allan RN, Keighley MR (2000) Risk factors for intra-abdominal sepsis after surgery in Crohn's disease. Dis Colon Rectum 43(8):1141–1145
Mege D et al (2017) Does faecal diversion prevent morbidity after ileocecal resection for Crohn's disease? Retrospective series of 80 cases. ANZ J Surg 87(9):E74–e79
Appau KA et al (2008) Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients. J Gastrointest Surg 12(10):1738–1744
Gastinger I et al (2005) Protective defunctioning stoma in low anterior resection for rectal carcinoma. Br J Surg 92(9):1137–1142
Matthiessen P et al (2007) Defunctioning stoma reduces symptomatic anastomotic leakage after low anterior resection of the rectum for cancer: a randomized multicenter trial. Ann Surg 246(2):207–214
Silverberg MS et al (2005) Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 19:5a–36a
Beaupel N et al (2017) Preoperative oral polymeric diet enriched with transforming growth factor-beta 2 (Modulen) could decrease postoperative morbidity after surgery for complicated ileocolonic Crohn's disease. Scand J Gastroenterol 52(1):5–10
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213
Heneghan HM et al (2013) Laparoscopic colorectal surgery for obese patients: decreased conversions with the hand-assisted technique. J Gastrointest Surg 17(3):548–554
Myrelid P et al (2012) Split stoma in resectional surgery of high-risk patients with ileocolonic Crohn's disease. Colorectal Dis 14(2):188–193
Delaney CP et al (2001) 'Fast track' postoperative management protocol for patients with high co-morbidity undergoing complex abdominal and pelvic colorectal surgery. Br J Surg 88(11):1533–1538
Beyer-Berjot L et al (2013) Laparoscopic approach is feasible in Crohn's complex enterovisceral fistulas: a case-match review. Dis Colon Rectum 56(2):191–197
Aytac E et al (2013) Factors affecting morbidity after conversion of laparoscopic colorectal resections. Br J Surg 100(12):1641–1648
Bollegala N, Jackson TD, Nguyen GC (2016) Increased postoperative mortality and complications among elderly patients with inflammatory bowel diseases: an analysis of the national surgical quality improvement program cohort. Clin Gastroenterol Hepatol 14(9):1274–1281
Yang SS et al (2012) Risk factors for complications after bowel surgery in Korean patients with Crohn's disease. J Korean Surg Soc 83(3):141–148
Huang W et al (2015) Risk factors for postoperative intra-abdominal septic complications after surgery in Crohn's disease: a meta-analysis of observational studies. J Crohns Colitis 9(3):293–301
Brouquet A et al (2018) Anti-TNF therapy is associated with an increased risk of postoperative morbidity after surgery for ileocolonic Crohn disease: results of a prospective nationwide cohort. Ann Surg 267(2):221–228
Soop M et al (2009) Safety, feasibility, and short-term outcomes of laparoscopically assisted primary ileocolic resection for Crohn's disease. Surg Endosc 23(8):1876–1881
Goyer P et al (2009) Impact of complex Crohn's disease on the outcome of laparoscopic ileocecal resection: a comparative clinical study in 124 patients. Dis Colon Rectum 52(2):205–210
Nguyen SQ et al (2009) Laparoscopic resection for Crohn's disease: an experience with 335 cases. Surg Endosc 23(10):2380–2384
Morar PS et al (2015) Determining predictors for intra-abdominal septic complications following ileocolonic resection for Crohn's disease-considerations in pre-operative and peri-operative optimisation techniques to improve outcome. J Crohns Colitis 9(6):483–491
Pinto RA et al (2011) Laparoscopy for recurrent Crohn's disease: how do the results compare with the results for primary Crohn's disease? Colorectal Dis 13(3):302–307
Aytac E et al (2012) Is laparoscopic surgery for recurrent Crohn's disease beneficial in patients with previous primary resection through midline laparotomy? A case-matched study. Surg Endosc 26(12):3552–3556
Li Y et al (2016) Association of preoperative narcotic use with postoperative complications and prolonged length of hospital stay in patients with Crohn disease. JAMA Surg 151(8):726–734
Valizadeh N et al (2017) Impact of preoperative steroid or immunosuppressant use on short-term outcomes following colectomy in Crohn's disease patients. Tech Coloproctol 21(3):217–223
Ihnat P et al (2016) Diverting ileostomy in laparoscopic rectal cancer surgery: high price of protection. Surg Endosc 30(11):4809–4816
Li W et al (2017) Factors associated with hospital readmission following diverting ileostomy creation. Tech Coloproctol 21(8):641–648
Geltzeiler CB et al (2015) Trends in the surgical management of Crohn's disease. J Gastrointest Surg 19(10):1862–1868
Neary PM, Aiello AC, Stocchi L, Shawki S, Steele SR, Delaney CP, Hull T, Holubar S (2019) High risk elective ileocolic anastomosis for Crohn’s disease; when is diversion indicated? J Crohns Colitis 13(7):856–863
Nguyen GC, Elnahas A, Jackson TD (2014) The impact of preoperative steroid use on short-term outcomes following surgery for inflammatory bowel disease. J Crohns Colitis 8(12):1661–1667
Lee Y et al (2012) A laparoscopic approach reduces short-term complications and length of stay following ileocolic resection in Crohn's disease: an analysis of outcomes from the NSQIP database. Colorectal Dis 14(5):572–577
Gionchetti P et al (2017) 3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: part 2: surgical management and special situations. J Crohns Colitis 11(2):135–149
Gardenbroek TJ et al (2013) Single-port versus multiport laparoscopic ileocecal resection for Crohn's disease. J Crohns Colitis 7(10):e443–e448
Lee JS et al (2016) The importance of the Crohn's disease activity index in surgery for small bowel Crohn's disease. J Visc Surg 153(5):339–345
Zerbib P et al (2010) Pre-operative management is associated with low rate of post-operative morbidity in penetrating Crohn's disease. Aliment Pharmacol Ther 32(3):459–465
Dr Gorgun is a consultant for Boston Scientific and Lumendi. Dr Delaney has been a consultant for Takeda and Merck in 2018. Drs Yoon, Stocchi, Holubar, Aiello, Shawki, Steele, and Hull have no conflicts of interest or financial ties to disclose.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Yoon, Y.S., Stocchi, L., Holubar, S. et al. When should we add a diverting loop ileostomy to laparoscopic ileocolic resection for primary Crohn’s disease?. Surg Endosc (2020). https://doi.org/10.1007/s00464-020-07670-w
- Crohn’s disease